ArticleBMC infectious diseases2023
Psittacosis caused severe community-acquired pneumonia accompanied by acute hypoxic respiratory failure: a multicenter retrospective cohort study from China.
Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 21 citations in OpenAlex.
- Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired pneumonia: an observational controlled before-after clinical trial.BMC infectious diseases · 2025Trial
- Rapid diagnosis ofExperimental and therapeutic medicine · 2026Article
- Targeted next-generation sequencing improves diagnosis and antimicrobial stewardship in Chlamydia psittaci pneumonia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- The re-emergence of psittacosis in China: a scoping review of epidemiology, diagnostics, and One Health priorities.Science in One Health · 2026Review
- Antimicrobial Management of SevereInfection and drug resistance · 2026Review
- Clinical Characteristics and Machine Learning-Based Severity Classification ofInfection and drug resistance · 2026Article
- Systemic inflammation, multi-organ injury, and acute kidney risk in psittacosis pneumonia: a biomarker-driven clinical characterization.Frontiers in cellular and infection microbiology · 2026Article
- Review
- Clinical characteristics and risk factors associated with severe community-acquired pneumonia infected byMicrobiology spectrum · 2025Article
- Psittacosis pneumonia with the reversed halo sign: a case report and literature review.BMC infectious diseases · 2025Review
- Spatial analysis and prediction of psittacosis in Zhejiang Province, China, 2019-2024.Frontiers in public health · 2025Article
- Community-AcquiredCase reports in infectious diseases · 2025Article
- Analysis of Risk Factors for Severe Pneumonia Progression in Chlamydia psittaci Infections: A Retrospective Study.International journal of general medicine · 2025Article
- Comprehensive insights into pathogen distribution, clinical features, and outcomes in pediatric severe pneumonia.Frontiers in cellular and infection microbiology · 2025Article
- Epidemiological characteristics of human psittacosis in Guangzhou, China, January 2021 to June 2024.Frontiers in public health · 2025Article
- Liver Function Abnormalities in Patients withInfection and drug resistance · 2025Article
- Epidemiological characteristics of human psittacosis in Guangdong Province, China, 2019-2024.Frontiers in public health · 2025Article
- Clinical experience with fluoroquinolones for treatment of severeFrontiers in medicine · 2025Article
- Clinical application and evaluation of metagenomic next-generation sequencing in pathogen detection for suspected central nervous system infections.Scientific reports · 2024Article
- Evaluation of clinical characteristics and risk factors associated with Chlamydia psittaci infection based on metagenomic next-generation sequencing.BMC microbiology · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
19 authors at 10 institutions in 1 country.
Funding
Abstract
introductionPsittacosis can cause severe community-acquired pneumonia (CAP). The clinical manifestations of psittacosis range from subclinical to fulminant psittacosis with multi-organ failure. It is essential to summarize the clinical characteristic of patients with severe psittacosis accompanied by acute hypoxic respiratory failure (AHRF).
methodsThis retrospective study included patients with severe psittacosis caused CAP accompanied by AHRF from 19 tertiary hospitals of China. We recorded the clinical data, antimicrobial therapy, respiratory support, complications, and outcomes. Chlamydia psittaci was detected on the basis of metagenomic next-generation sequencing performed on bronchoalveolar lavage fluid samples. Patient outcomes were compared between the treatment methods.
resultsThis study included 45 patients with severe CAP and AHRF caused by psittacosis from April 2018 to May 2021. The highest incidence of these infections was between September and April. There was a history of poultry contact in 64.4% of the patients. The median PaO
conclusionPsittacosis caused severe CAP seems not rare, especially in the patients with the history of exposure to poultry or birds. Empirical treatment that covers atypical pathogens may benefit such patients, which fluoroquinolones might be considered as an alternative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.